Jiling M. Niu

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance.

Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance.

Journal: Frontiers in immunology

Published: April 02, 2026

Optimal treatment strategies for EGFR mutant advanced lung adenocarcinoma patients with targeted therapy resistance and correlation analysis of PD-L1 expression with ICI efficacy.

Optimal treatment strategies for EGFR mutant advanced lung adenocarcinoma patients with targeted therapy resistance and correlation analysis of PD-L1 expression with ICI efficacy.

Journal: Scientific reports

Published: February 15, 2026

Weekly cisplatin and nab-paclitaxel neoadjuvant chemoradiotherapy increases pathological complete response in locally advanced esophageal squamous cell carcinoma: A real-world study.

Weekly cisplatin and nab-paclitaxel neoadjuvant chemoradiotherapy increases pathological complete response in locally advanced esophageal squamous cell carcinoma: A real-world study.

Journal: Oncology letters

Published: November 09, 2025

Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: a propensity score-matched study.

Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: a propensity score-matched study.

Journal: Future oncology (London, England)

Published: September 29, 2025

Restoring osimertinib sensitivity in EGFR-mutant NSCLC: the role of anlotinib in modulating Wnt/β-catenin/YAP pathways.

Restoring osimertinib sensitivity in EGFR-mutant NSCLC: the role of anlotinib in modulating Wnt/β-catenin/YAP pathways.

Journal: American journal of cancer research

Published: September 06, 2025

Continuing Immunotherapy Beyond Progression Prolongs the Survival of Patients With Extensive-Stage Small-Cell Lung Cancer: A Multicenter Retrospective Analysis.

Continuing Immunotherapy Beyond Progression Prolongs the Survival of Patients With Extensive-Stage Small-Cell Lung Cancer: A Multicenter Retrospective Analysis.

Journal: Cancer medicine

Published: May 10, 2025

Role of circular RNAs in cancer therapy resistance.

Role of circular RNAs in cancer therapy resistance.

Journal: Molecular cancer

Published: January 06, 2025

Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions.

Macrophages in the premetastatic and metastatic niche: key functions and therapeutic directions.

Journal: Journal of translational medicine

Published: December 28, 2024

Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes.

Evaluating the impact of COVID-19 on cancer care: a comprehensive analysis of treatment modifications, risk factors, and patient outcomes.

Journal: BMC infectious diseases

Published: December 08, 2024

Construction of a nomogram to guide prophylactic cranial irradiation in extensive‑stage small cell lung cancer.

Construction of a nomogram to guide prophylactic cranial irradiation in extensive‑stage small cell lung cancer.

Journal: Oncology letters

Published: November 20, 2024

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Formation of metal-microplastic complexes in lung adenocarcinoma is associated with increased risk of cancer progression.

Journal: Journal of hazardous materials

Published: November 19, 2024

Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer.

Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer.

Journal: BMC cancer

Published: November 08, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026